Amphion Innovations PLC Directorate Change (9662S)

TIDMAMP

RNS Number : 9662S

Amphion Innovations PLC

29 June 2018

AMPHION INNOVATIONS PLC

("Amphion" or "the Company")

Appointment of a New Director

London and New York, 29 June 2018 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces the appointment of Mr Philip Tansey as Non-executive director to the Company, effective immediately.

Philip Tansey is a qualified chartered accountant (ICAEW) and holds an honours degree in Biochemistry from Manchester University. He has over 25 years' experience, primarily in financial services, having started his career at Salomon Brothers. Until January 2017, he acted as Chief Financial Officer to the AIM listed company Panmure Gordon & Co. plc and prior to joining them in May 2011 he worked as a Managing Director for BGC Partners Inc. the NASDAQ listed inter-dealer broker.

Save as disclosed below, there are no further details required to be disclosed pursuant to schedule 2(g) of the AIM rules.

Philip Tansey (age 59) is, or has been in the previous five years, a director or partner, of the following companies:

 
 Current appointments        Past appointments 
 Baby Break and Toddler      Durlacher Research Limited 
  Break Limited 
 Tansey Associates Limited   Life Capital Limited 
 To Health Limited           Panmure General Partner 
                              Limited 
                             Panmure Gordon & Co. Limited 
                             Panmure Gordon (Broking) 
                              Limited 
                             Panmure Gordon (UK) Limited 
                             Panmure Gordon Securities 
                              Limited 
                             Primextend Limited 
                             Rotherfield Nominees Limited 
                             United Energy Limited 
                             United Energy Properties 
                              Limited 
                             Web-Angel Limited 
                             Web-Angel Services Limited 
 

Mr Tansey was a director of Alfresco Leisure Publications Plc ("Alfresco") and its subsidiaries, Premier Guides Limited ("Premier Guides") and Telfo Limited ("Telfo"), all of which were placed into administration in 1992. Alfresco Leisure Publications and Premier Guides were dissolved on 16 November 1999 and Telfo was dissolved on 7 December 1993. The administrators of Premier Guides showed a deficiency of GBP0.6 million (excluding amounts owed to Alfresco) as regards to unsecured creditors. The administrators of Telfo showed a deficiency to creditors of GBP0.7 million.

Mr Tansey currently holds no beneficial interest in the Company.

For further information please contact:

 
 Amphion Innovations                                                                     Tel: [phone] 
 Charlie Morgan 
 
 Panmure Gordon (UK) Limited (Nominated                                                                 Tel: +44 (0)20 
  Adviser and Corporate Broker)                                                                              7886 2500 
 Freddy Crossley / Emma Earl 
  (Corporate Finance) 
 Charlie Leigh-Pemberton 
  (Corporate Broking) 
 
 Northland Capital Partners                                           Tel: +44 (0)20 
  Limited (Joint Corporate Broker)                                     3861 6625 
 David Hignell (Corporate 
  Finance) 
 John Howes (Corporate 
  Broking) 
 
 Walbrook PR                                                                        Tel: [phone] 
                                                                                     8780 or 
 Paul McManus / Anna Dunphy                                                        [e-mail] 
 
 
 

About Amphion Innovations plc - www.amphionplc.com

Amphion Innovations is a developer of medical, life science and technology businesses. We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BOAKMGZVKRNGRZM

(END) Dow Jones Newswires

June 29, 2018 02:01 ET (06:01 GMT)